(Q56.3) Pseudohermaphroditism, unspecified

More details coming soon

Icon
7 198 in individuals diagnosis pseudohermaphroditism, unspecified confirmed

Diagnosis pseudohermaphroditism, unspecified is diagnosed Women are 18.12% more likely than Men

2 947

Men receive the diagnosis pseudohermaphroditism, unspecified

0 (less than 0.1%)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
4 251

Women receive the diagnosis pseudohermaphroditism, unspecified

0 (less than 0.1%)

Died from this diagnosis.

Risk Group for the Disease pseudohermaphroditism, unspecified - Men aged 0 and Women aged 15-19

Icon
In Men diagnosis is most often set at age 0-5, 10-24, 35-39, 60-64
Icon
Less common in men the disease occurs at Age 5-9, 25-34, 40-59, 65-95+Less common in women the disease occurs at Age 25-29, 35-44, 50-95+
Icon
In Women diagnosis is most often set at age 0-24, 30-34, 45-49

Disease Features pseudohermaphroditism, unspecified

Icon
Absence or low individual and public risk
Icon

Pseudohermaphroditism, unspecified - what does this mean

Pseudohermaphroditism, unspecified is a condition in which an individual is born with ambiguous external genitalia, meaning that the genitalia does not clearly indicate whether the individual is male or female. this can be caused by a variety of congenital conditions, including an abnormal balance of hormones, chromosomal abnormalities, or other unknown factors.

What happens during the disease - pseudohermaphroditism, unspecified

Pseudohermaphroditism, unspecified is caused by a disruption in the normal process of sexual differentiation in the womb. this disruption can be caused by a genetic mutation, endocrine disorder, or environmental factors that interfere with the normal development of the gonads and the production of hormones. as a result, the individual may have a combination of male and female physical characteristics, or atypical genitalia.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Physical examination
  • Genetic testing
  • Hormonal testing
  • Ultrasound imaging
  • Chromosome analysis
  • CT scan or MRI
  • Laparoscopy
  • Blood tests

Treatment and Medical Assistance

Main goal of the treatment: To provide proper care and treatment for individuals with Pseudohermaphroditism, unspecified.
  • Identify the underlying cause of the condition and provide appropriate medical treatment.
  • Provide counseling for the patient and their family to help them understand the condition and the available treatment options.
  • Provide access to support groups and other resources for individuals with Pseudohermaphroditism, unspecified.
  • Perform laboratory tests to determine the patient’s hormone levels and genetic makeup.
  • Perform imaging tests such as ultrasound or MRI to determine the patient’s internal structure.
  • Provide medical care and treatments to address any underlying medical conditions.
  • Provide surgical interventions to correct any anatomical abnormalities.
  • Provide psychological support to help the patient and family manage the condition.
  • Provide education and resources to help the patient and family understand the condition and available treatments.
Icon
8 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Pseudohermaphroditism, unspecified - Prevention

Pseudohermaphroditism, unspecified can be prevented by avoiding exposure to environmental toxins, maintaining a healthy lifestyle, and avoiding activities that may increase the risk of hormonal imbalances. additionally, pregnant women should be monitored for any signs of hormonal imbalances and any potential risk factors should be addressed prior to the birth of the child.